Product Information
FLURBIPROFEN 100 MG TABLET is a generic product labeled by Genus Lifesciences Inc., priced at $3.1734 per EA under NDC 64950021810. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application on May 31, 1995.
Strength
100 mg/1
Manufacturer
Genus Lifesciences Inc.NDC
64950021810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLURBIPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA074431FDA Approved
5/31/1995
On Market Since
11/1/2024
Pharmacological Classes
Price Statistics
The NADAC for FLURBIPROFEN 100 MG TABLET has been published 86 times since Feb 12, 2025, and over the history we have for it it has risen 873.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1734 per EA |
|---|---|
| All-time high | $3.3163 (Jul 15, 2026) |
| All-time low | $0.3101 (Feb 19, 2025) |
| 52-week high | $3.3163 |
| 52-week low | $3.1734 |
| Median price | $3.2480 |
| Average price | $2.3352 |
| Largest weekly change | +957.3% (Aug 20, 2025) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Genus Lifesciences Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Flurbiprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLURBIPROFEN 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLURBIPROFEN 100 MG TABLET, manufactured by Genus Lifesciences Inc., is $3.1734 per EA (NDC 64950021810), effective Sep 30, 2026.
How has the price of FLURBIPROFEN 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLURBIPROFEN 100 MG TABLET has risen 873.6%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for FLURBIPROFEN 100 MG TABLET?
Since Feb 12, 2025, the NADAC for FLURBIPROFEN 100 MG TABLET has ranged from a low of $0.3101 (Feb 19, 2025) to a high of $3.3163 (Jul 15, 2026), with a median of $3.2480 per EA.
Are there cheaper alternatives to FLURBIPROFEN 100 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLURBIPROFEN 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FLURBIPROFEN 100 MG TABLET?
FLURBIPROFEN 100 MG TABLET (NDC 64950021810) is labeled by Genus Lifesciences Inc., and CMS classifies it as a generic product.